Spruce Biosciences
SPRB · NASDAQ
$41.23+$0.83 (+2.05%)TodayMarket closed ·
Prev close $40.40
EPS: actual vs estimate
Beat the estimate in 3 of the last 8 quarters, by 32.0% on average
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | -$5.92 | -$6.68 | −12.9% |
| Q1 FY26 | -$8.99 | -$8.94 | +0.6% |
| Q4 FY25 | -$8.15 | -$11.28 | −38.5% |
| Q3 FY25 | -$14.21 | -$14.58 | −2.6% |
| Q2 FY25 | -$19.51 | -$3.50 | +82.1% |
| Q1 FY25 | -$16.42 | -$24.00 | −46.2% |
| Q4 FY24 | -$16.07 | -$42.75 | −166.1% |
| Q3 FY24 | -$18.17 | -$15.75 | +13.3% |
Earnings calls
- Special Call - Spruce Biosciences, Inc.
- H.C. Wainwright 26th Annual Global Investment Conference 2024
- Jefferies 2024 Global Healthcare Conference
- 2023 Earnings Call
- Credit Suisse 31st Annual Healthcare Conference
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.